Page last updated: 2024-08-17

ampicillin and panipenem-betamipron

ampicillin has been researched along with panipenem-betamipron in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, T; Fukuoka, T; Inoue, H; Ohya, S1
Fukuda, T; Furuta, Y; Minami, S; Mitsuyama, J; Nakata, M; Nomura, N; Takahata, M; Yamada, H1
Ameshima, S; Demura, Y; Ishizaki, T; Kadowaki, M; Miyamori, I; Mizuno, S; Uesaka, D1

Trials

1 trial(s) available for ampicillin and panipenem-betamipron

ArticleYear
Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
    Chest, 2005, Volume: 127, Issue:4

    Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Alanine; Clindamycin; Female; Humans; Injections, Intravenous; Male; Pneumonia, Aspiration; Prospective Studies; Severity of Illness Index; Sulbactam; Thienamycins

2005

Other Studies

2 other study(ies) available for ampicillin and panipenem-betamipron

ArticleYear
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:7

    Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin

2001
[In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:4

    Topics: 4-Quinolones; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; beta-Alanine; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Meropenem; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazines; Rats; Thienamycins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

2002